Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FORWARD PHARMA A/S

(FWP)
Delayed Nasdaq  -  11:40 2022-12-02 am EST
2.810 USD   -4.58%
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/21Forward Pharma A/s : Amended and Restated Articles of Association, dated November 9, 2022 - Form 6-K
PU
11/21Rising COVID Cases in China, Plunging Oil Prices Drag European Equities Lower in Monday Trading
MT
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Valuation
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization1 3 51517436,944,047,741,9
Enterprise Value (EV)1 3 37764,1-45,6-33,6-31,3-28,9
P/E ratio -106x0,19x-4,23x-10,4x-7,17x-22,0x
Yield ------
Capitalization / Revenue ------
EV / Revenue ------
EV / EBITDA -61,0x-1,03x3,86x6,35x9,26x-
Price to Book 22,7x1,94x0,45x0,57x0,62x0,59x
Nbr of stocks (in thousands) 33 4806 7416 7646 7916 7917 019
Reference price (USD) 10525,85,466,497,035,97
Announcement Date 04/18/201704/30/201804/04/201904/24/202004/14/202104/08/2022
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales ------
EBITDA1 -55,3-62,2-11,8-5,28-3,39-
Operating profit (EBIT)1 -55,4-62,4-11,8-5,28-3,39-3,87
Operating Margin ------
Pre-Tax Profit (EBT)1 -54,51 184-8,93-4,22-6,45-1,89
Net income1 -33,3917-8,72-4,22-6,45-1,89
Net margin ------
EPS2 -0,99136-1,29-0,62-0,98-0,27
Dividend per Share ------
Announcement Date 04/18/201704/30/201804/04/201904/24/202004/14/202104/08/2022
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt1 ------
Net Cash position1 13911082,577,679,170,8
Leverage (Debt / EBITDA) 2,51x1,76x6,98x14,7x23,4x-
Free Cash Flow1 -14,3-18,1-20,7-1,45-1,43-3,01
ROE (Net Profit / Equities) -20,1%747%-10,1%-5,28%-8,26%-2,53%
Shareholders' equity1 16612385,979,978,174,7
ROA (Net Profit / Asset) -20,0%-28,4%-7,61%-4,09%-2,68%-3,20%
Assets1 166-3 22411510324159,0
Book Value Per Share2 4,6313,312,111,411,410,1
Cash Flow per Share2 1,7216,312,211,411,510,1
Capex1 0,030,00----
Capex / Sales ------
Announcement Date 04/18/201704/30/201804/04/201904/24/202004/14/202104/08/2022
1 USD in Million
2 USD
Key data
Capitalization (USD) 19 926 227
Number of employees 4
Free-Float 6,85%
Free-Float capitalization (USD) 1 364 627
Avg. Exchange 20 sessions () 5 152
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,03%
EPS & Dividend
Change in Enterprise Value/EBITDA